Home › Funds › NEXTBio Capital Management LP › CMPS
NEXTBio Capital Management LP position in CMPS
COMPASS PATHWAYS PLC · Health Care
NEXTBio Capital Management LP reported holding 1,775,759 shares of CMPS (COMPASS PATHWAYS PLC) in its Q3 2026 13F filing — a position valued at US$22.1M, representing 9.62% of its reported portfolio and ranking #3 among its reported holdings. NEXTBio Capital Management LP has disclosed CMPS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NEXTBio Capital Management LP's CMPS position evolved
NEXTBio Capital Management LP first disclosed a stake in CMPS in Q4 2025 at 752,631 shares (US$5.2M). The position peaked in Q2 2026 at 1,775,759 shares, worth US$25.1M. Across 4 filings, NEXTBio Capital Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,775,759 shares valued at US$22.1M. Notable position changes include a 169% increase in Q1 2026 (shares rose 156% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 752.63K | $5.19M | New |
| Q1 2026 | 2.02M | $11.18M | Add |
| Q2 2026 | 1.78M | $25.13M | Reduce |
| Q3 2026 | 1.78M | $22.09M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CMPS and 13F data
CMPS (COMPASS PATHWAYS PLC) is a Health Care company. 62 other funds we track also report a position in CMPS — the largest reported positions include Deep Track Capital, LP (US$172.1M), RTW INVESTMENTS, LP (US$151.4M), BIT Capital GmbH (US$111.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPS
- Deep Track Capital, LP 12.16M sh · $172.09M · Q2 2026
- RTW INVESTMENTS, LP 10.70M sh · $151.42M · Q2 2026
- BIT Capital GmbH 8.97M sh · $111.56M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 5.00M sh · $70.75M · Q2 2026
- Logos Global Management LP 2.25M sh · $31.84M · Q2 2026
- Eagle Health Investments LP 2.06M sh · $29.16M · Q2 2026
- DAFNA Capital Management LLC 2.01M sh · $28.47M · Q2 2026
- Aisling Capital Management LP 1.73M sh · $21.55M · Q3 2026
- Creek Drive Management Group LLC 1.33M sh · $16.52M · Q3 2026
- Patient Square Capital LP 1.06M sh · $13.14M · Q3 2026
- Axxion S.A. 844.35K sh · $10.50M · Q3 2026
- Eversept Partners, LP 672.83K sh · $9.52M · Q2 2026
More on NEXTBio Capital Management LP
FAQ
How long has NEXTBio Capital Management LP held CMPS?
NEXTBio Capital Management LP has disclosed CMPS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is NEXTBio Capital Management LP's current position in CMPS?
As of Q3 2026, NEXTBio Capital Management LP holds 1.78M shares of CMPS (COMPASS PATHWAYS PLC), valued at $22.09M, representing 9.62% of its reported portfolio and ranking #3.
Has NEXTBio Capital Management LP been buying or selling CMPS?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP held unchanged its position in CMPS. The position peaked in Q2 2026 at 1.78M shares.
Which other funds hold CMPS?
Other major institutional holders of CMPS include Deep Track Capital, LP, RTW INVESTMENTS, LP, BIT Capital GmbH, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.